Researchers report on implementation of a nurse navigator and pretreatment care plans on time from diagnosis to treatment for patients with head and neck cancers.
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity.
[Cancer Management and Research] A review of 14 cases in which patients with well-differentiated thyroid cancer experienced adverse outcomes after surgical treatment of their disease.
[Cancer Management and Research] Chinese researchers present a review of a rare cancer and strategies for managing the most common adverse effect of its treatment.
Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.